TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 160 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2016. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $487,000 | +7.0% | 4,179 | -3.4% | 0.02% | -5.3% |
| Q4 2016 | $455,000 | -78.5% | 4,326 | -77.4% | 0.02% | -78.4% |
| Q3 2016 | $2,112,000 | -4.2% | 19,107 | +26.2% | 0.09% | 0.0% |
| Q2 2016 | $2,204,000 | +135.0% | 15,136 | +149.4% | 0.09% | +137.8% |
| Q4 2015 | $938,000 | -17.8% | 6,068 | -23.6% | 0.04% | -9.8% |
| Q2 2015 | $1,141,000 | -18.0% | 7,943 | -19.5% | 0.04% | -18.0% |
| Q1 2015 | $1,392,000 | – | 9,872 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL LP | 1,104,068 | $104,886,000 | 77.66% |
| Greywolf Capital Management LP | 472,135 | $46,694,000 | 10.17% |
| Consonance Capital Management LP | 263,732 | $26,083,000 | 4.28% |
| Moab Capital Partners | 83,132 | $8,222,000 | 3.77% |
| Raging Capital Management, LLC | 190,151 | $18,806,000 | 3.45% |
| Valentine Capital Asset Management, Inc. | 145,053 | $14,346,000 | 3.07% |
| Assured Investment Management LLC | 1,353,342 | $133,846,000 | 1.21% |
| Ativo Capital Management LLC | 22,828 | $2,258,000 | 0.99% |
| Perceptive Advisors | 56,602 | $5,598,000 | 0.67% |
| Jaffetilchin Investment Partners, LLC | 7,721 | $764,000 | 0.38% |